The global Lateral Flow Assays Market is set to hit US$15.68 billion by 2033, fueled by growing demand for rapid infectious disease testing, point-of-care diagnostics, and advances in AI-powered test interpretation. Rising adoption in home testing and decentralized healthcare continues to accelerate market growth. https://www.prnewswire.co.uk/news-releases/lateral-flow-assays-market-size-will-hit-us-15-68-billion-by-2033--driven-by-infectious-disease-testing-and-ai-powered-diagnostics--datam-intelligence-302550993.html